semaglutide news october 26 2025 China's Innovent says its GLP-1 works better than Novo's in diabetes study Wegovy and Ozempic maker forecasts

However, alongside their benefits, concerns over potential side effects have surfaced, leading to legal action against their manufacturers

IOP Conf Ser.: Earth Environ Sci 910:012044

On Thursday, though, officials at GIC and CVS Caremark, which manages state employee prescription drug coverage, announced that beginning July 1, state employees will have fewer choices of covered GLP-1 drugs

The GAT architecture could be adapted for other multi-target therapeutic applications beyond incretin receptor agonists

But like all medications, it is not one-size-fits-all

Assessment It is suggested that at an initial appointment details of any pigmented or solitary lesion arising on the feet is recorded in the patient's notes with a description including location, size, colour and shape